why am i not losing weight in tirzepatide on tirzepatide? Every reason and how to fix it Why Is Tirzepatide Not Working

ISBN 978-0-12-182246-0

Semaglutide, a GLP-1 receptor agonist, mimics the natural incretin hormone GLP-1 to enhance insulin secretion, slow gastric emptying, and increase satiety

Data Analysis and Synthesis of Results Data analysis followed the JBI methodological framework for scoping reviews, emphasizing descriptive mapping and transparent presentation of evidence rather than statistical pooling or effect estimation

Hemoglobin A1c (HbA1c) reductions, which reflect average glucose control over the preceding 23 months, become measurable at 1216 weeks, with maximal effects generally achieved by 6 months of therapy

Patients with significant kidney disease, personal or family history of medullary thyroid cancer, or active pancreatitis should not use semaglutide

Apps and wearable devices can track diet, exercise, and glucose levels